Xencor XNCR
NASDAQ XNCR
$24.84 +0.07 (+0.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xencor (XNCR) Income from Non-Controlling Interests (2023 - 2025)

Updated

Xencor's Income from Non-Controlling Interests came in at -$214,000 for FY2025, compared with -$3.92 million in FY2024.

Analysis

Xencor (XNCR) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Income from Non-Controlling Interests at -$3.92 million in FY2024 and -$163,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Xencor 1.85 Bn 262.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -214,000.00
Dec 31, 2024 -647,000.00
Sep 30, 2024 -1.15 Mn
Jun 30, 2024 -1.45 Mn
Mar 31, 2024 -676,000.00
Dec 31, 2023 -163,000.00
API Access

Xencor Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=XNCR&period=max&api_key=YOUR_API_KEY